Tandem myeloablative ¹³¹I-rituximab radioimmunotherapy and high-dose chemotherapy in refractory/relapsed non-Hodgkin lymphoma patients

By Deshayes Emmanuel   Kraeber-Bodéré Françoise   Vuillez Jean-Philippe   Bardiès Manuel   Teulon Isabelle   Pouget Jean-Pierre  

Immunotherapy, Vol. 5, Iss. 12, 2013-12 ,pp. : 1283-1286

Future Medicine

Access to resources Recommend Favorite

Relation between S-phase fraction of myeloma cells and anemia in patients with multiple myeloma - a randomized multicenter study. The European study group of erythropoietin (Epoetin Beta) treatment in multiple myeloma and non-Hodgkin's lymphoma

By Fossa A.   Brandhorst D.   Myklebust J.H.   Seeber S.   Nowrousian M.R.  

Experimental Hematology, Vol. 27, Iss. 11, 1999-11 ,pp. : 1621-1626

Elsevier

Access to resources Recommend Favorite

High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin’s lymphoma

By Ianni Mauro Di   Ballanti Stelvio   Iodice Giuseppe   Reale Antonia   Falzetti Franca   Minelli Olivia   Serio Gabriella   Martelli Massimo F   Dammacco Franco   Vacca Angelo   Ria Roberto  

Hematology, Vol. 17, Iss. 1, 2012-01 ,pp. : 23-27

Maney Publishing

Access to resources Recommend Favorite

Clonality detection in apheresis products from multiple myeloma and non-Hodgkin lymphoma patients

By Araujo M.J.   Carvalhais A.   Campos A.   Vaz C.P.   Campilho F.   Pimentel P.   Barbosa I.L.  

Transplantation Proceedings, Vol. 32, Iss. 8, 2000-12 ,pp. : 2676-2676

Elsevier

Access to resources Recommend Favorite

Immune dysfunction despite high levels of immunoregulatory cytokine gene expression in autologous peripheral blood stem cell transplanted non-Hodgkin's lymphoma patients

By Singh R.K.   Varney M.L.   Ino K.   Vose J.M.   Bierman P.J.   Talmadge J.E.  

Experimental Hematology, Vol. 28, Iss. 5, 2000-05 ,pp. : 499-507

Elsevier

Access to resources Recommend Favorite